INVO Bioscience, Inc. (INVO)
USD 0.83
(-2.0%)
USD 0.83
(-2.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -6.76 Million USD | 36.32% |
| 2022 | -10.62 Million USD | -103.71% |
| 2021 | -5.21 Million USD | 5.41% |
| 2020 | -5.51 Million USD | -208.43% |
| 2019 | -1.78 Million USD | 32.12% |
| 2018 | -2.63 Million USD | -311.3% |
| 2017 | -640.42 Thousand USD | 69.65% |
| 2016 | -2.11 Million USD | -254.65% |
| 2015 | -595.07 Thousand USD | 64.59% |
| 2014 | -1.68 Million USD | -177.67% |
| 2013 | -605.23 Thousand USD | -9.58% |
| 2012 | -552.29 Thousand USD | 21.45% |
| 2011 | -703.12 Thousand USD | 53.6% |
| 2010 | -1.51 Million USD | 17.76% |
| 2009 | -1.84 Million USD | 1.01% |
| 2008 | -1.86 Million USD | -4182.57% |
| 2007 | -43.46 Thousand USD | -471.77% |
| 2006 | -7602.00 USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -946.37 Thousand USD | 37.26% |
| 2024 Q2 | -1.9 Million USD | -101.07% |
| 2023 Q4 | -1.5 Million USD | -70.2% |
| 2023 Q1 | -2.3 Million USD | 15.15% |
| 2023 Q2 | -2.06 Million USD | 10.42% |
| 2023 FY | -6.76 Million USD | 36.32% |
| 2023 Q3 | -886.29 Thousand USD | 57.1% |
| 2022 Q3 | -2.52 Million USD | 5.83% |
| 2022 FY | -10.62 Million USD | -103.71% |
| 2022 Q4 | -2.71 Million USD | -7.64% |
| 2022 Q1 | -2.7 Million USD | -636.37% |
| 2022 Q2 | -2.68 Million USD | 0.71% |
| 2021 Q2 | -1.88 Million USD | -20.95% |
| 2021 Q3 | -2.27 Million USD | -20.52% |
| 2021 FY | -5.21 Million USD | 5.41% |
| 2021 Q4 | 503.55 Thousand USD | 122.15% |
| 2021 Q1 | -1.55 Million USD | 12.75% |
| 2020 FY | -5.51 Million USD | -208.43% |
| 2020 Q3 | -1.26 Million USD | -19.27% |
| 2020 Q4 | -1.78 Million USD | -41.02% |
| 2020 Q2 | -1.06 Million USD | 23.89% |
| 2020 Q1 | -1.39 Million USD | -88.51% |
| 2019 FY | -1.78 Million USD | 32.12% |
| 2019 Q2 | -65.79 Thousand USD | 81.15% |
| 2019 Q1 | -349.11 Thousand USD | 32.01% |
| 2019 Q3 | -632.36 Thousand USD | -861.1% |
| 2019 Q4 | -740.82 Thousand USD | -17.15% |
| 2018 Q3 | -189.88 Thousand USD | 89.39% |
| 2018 FY | -2.63 Million USD | -311.3% |
| 2018 Q1 | -140.28 Thousand USD | 28.79% |
| 2018 Q4 | -513.44 Thousand USD | -170.4% |
| 2018 Q2 | -1.79 Million USD | -1176.31% |
| 2017 Q4 | -197 Thousand USD | -36.53% |
| 2017 FY | -640.42 Thousand USD | 69.65% |
| 2017 Q3 | -144.29 Thousand USD | -8.98% |
| 2017 Q2 | -132.41 Thousand USD | 20.57% |
| 2017 Q1 | -166.7 Thousand USD | 38.33% |
| 2016 FY | -2.11 Million USD | -254.65% |
| 2016 Q4 | -270.29 Thousand USD | -30.34% |
| 2016 Q3 | -207.37 Thousand USD | 85.72% |
| 2016 Q2 | -1.45 Million USD | -703.75% |
| 2016 Q1 | -180.66 Thousand USD | 23.78% |
| 2015 Q4 | -237.02 Thousand USD | -99.58% |
| 2015 Q3 | -118.76 Thousand USD | -10.54% |
| 2015 Q1 | -131.84 Thousand USD | 0.0% |
| 2015 Q2 | -107.44 Thousand USD | 18.51% |
| 2015 FY | -595.07 Thousand USD | 64.59% |
| 2014 FY | -1.68 Million USD | -177.67% |
| 2013 FY | -605.23 Thousand USD | -9.58% |
| 2012 FY | -552.29 Thousand USD | 21.45% |
| 2011 Q1 | -174.12 Thousand USD | 57.76% |
| 2011 Q2 | -204.59 Thousand USD | -17.5% |
| 2011 Q3 | -172.48 Thousand USD | 15.69% |
| 2011 Q4 | -152.37 Thousand USD | 11.66% |
| 2011 FY | -703.12 Thousand USD | 53.6% |
| 2010 FY | -1.51 Million USD | 17.76% |
| 2010 Q1 | -428.12 Thousand USD | 8.71% |
| 2010 Q4 | -412.25 Thousand USD | -12.95% |
| 2010 Q2 | -310.01 Thousand USD | 27.59% |
| 2010 Q3 | -364.97 Thousand USD | -17.73% |
| 2009 Q3 | -294.41 Thousand USD | 32.11% |
| 2009 Q1 | -645.7 Thousand USD | 64.54% |
| 2009 FY | -1.84 Million USD | 1.01% |
| 2009 Q4 | -468.96 Thousand USD | -59.29% |
| 2009 Q2 | -433.65 Thousand USD | 32.84% |
| 2008 Q3 | -13.16 Thousand USD | -38.32% |
| 2008 Q2 | -9520.00 USD | 46.61% |
| 2008 Q1 | -17.83 Thousand USD | 8.85% |
| 2008 Q4 | -1.82 Million USD | -13728.53% |
| 2008 FY | -1.86 Million USD | -4182.57% |
| 2007 FY | -43.46 Thousand USD | -471.77% |
| 2007 Q4 | -19.56 Thousand USD | -154.75% |
| 2007 Q2 | -13 Thousand USD | -303.1% |
| 2007 Q1 | -3225.00 USD | 0.0% |
| 2007 Q3 | -7679.00 USD | 40.93% |
| 2006 FY | -7602.00 USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 52.878% |
| Cerus Corporation | -30.05 Million USD | 77.483% |
| OrthoPediatrics Corp. | -25.76 Million USD | 73.736% |
| PetVivo Holdings, Inc. | -10.62 Million USD | 36.287% |
| Talis Biomedical Corporation | -66.81 Million USD | 89.872% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 60.874% |
| Inogen, Inc. | -109.38 Million USD | 93.814% |
| Spectral AI, Inc. | -12.98 Million USD | 47.881% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 89.188% |
| CVRx, Inc. | -43.1 Million USD | 84.3% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -91.813% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | 45.549% |
| Orthofix Medical Inc. | -139.11 Million USD | 95.135% |
| Venus Concept Inc. | -28.3 Million USD | 76.095% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 87.475% |
| Bioventus Inc. | -81.72 Million USD | 91.72% |
| BrainsWay Ltd. | -4.92 Million USD | -37.348% |
| Envoy Medical, Inc. | -18.37 Million USD | 63.164% |
| electroCore, Inc. | -18.8 Million USD | 64.014% |
| IceCure Medical Ltd | -15.57 Million USD | 56.554% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 86.042% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 60.811% |
| MaxCyte, Inc. | -48.29 Million USD | 85.989% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | 43.396% |
| Nexalin Technology, Inc. | -5.69 Million USD | -18.799% |
| PAVmed Inc | -68.79 Million USD | 90.163% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 88.036% |
| RxSight, Inc. | -50.08 Million USD | 86.489% |
| Sight Sciences, Inc. | -57.27 Million USD | 88.185% |
| SI-BONE, Inc. | -46.93 Million USD | 85.581% |
| TELA Bio, Inc. | -44.07 Million USD | 84.646% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 87.503% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 86.841% |
| LivaNova PLC | -68.49 Million USD | 90.121% |
| 908 Devices Inc. | -42.75 Million USD | 84.173% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 96.097% |
| Nemaura Medical Inc. | -9.59 Million USD | 29.474% |
| NeuroPace, Inc. | -27.17 Million USD | 75.097% |
| LENSAR, Inc. | -12.22 Million USD | 44.663% |
| Apyx Medical Corporation | -17.25 Million USD | 60.791% |
| Cutera, Inc. | -156.23 Million USD | 95.668% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | 21.349% |
| BioSig Technologies, Inc. | -28.51 Million USD | 76.266% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 92.278% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 69.851% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 106.068% |
| Axonics, Inc. | -26.05 Million USD | 74.029% |
| Outset Medical, Inc. | -169.77 Million USD | 96.014% |
| IRIDEX Corporation | -10 Million USD | 32.376% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 93.801% |
| IRadimed Corporation | 20.03 Million USD | 133.776% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 17.924% |
| Telesis Bio, Inc. | -35.15 Million USD | 80.748% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 147.224% |
| Varex Imaging Corporation | 32.1 Million USD | 121.081% |
| Quipt Home Medical Corp. | 3.91 Million USD | 272.676% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 44.225% |
| Pulmonx Corporation | -61.93 Million USD | 89.074% |
| Dynatronics Corporation | -2.27 Million USD | -197.713% |
| Modular Medical, Inc. | -17.52 Million USD | 61.395% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 53.773% |
| Semler Scientific, Inc. | 22.25 Million USD | 130.406% |
| InMode Ltd. | 195.66 Million USD | 103.459% |
| Bruker Corporation | 436.9 Million USD | 101.549% |
| Cytosorbents Corporation | -31.2 Million USD | 78.317% |
| DexCom, Inc. | 597.7 Million USD | 101.132% |
| Align Technology, Inc. | 643.33 Million USD | 101.052% |
| Viveve Medical, Inc. | -21.55 Million USD | 68.602% |
| ZimVie Inc. | -30.93 Million USD | 78.127% |
| Movano Inc. | -29.69 Million USD | 77.207% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 75.697% |
| Nexalin Technology, Inc. | -5.69 Million USD | -18.799% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -91.813% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 97.099% |
| Profound Medical Corp. | -28.61 Million USD | 76.352% |
| Insulet Corporation | 220 Million USD | 103.076% |
| enVVeno Medical Corporation | -25.23 Million USD | 73.187% |
| Surmodics, Inc. | -5.64 Million USD | -19.879% |
| iCAD, Inc. | -7.68 Million USD | 11.989% |
| Nuwellis, Inc. | -17.63 Million USD | 61.616% |
| Biotricity, Inc. | -8.82 Million USD | 23.347% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 94.593% |
| Aethlon Medical, Inc. | -12.63 Million USD | 46.448% |
| InspireMD, Inc. | -21.14 Million USD | 67.993% |
| PAVmed Inc. | -68.79 Million USD | 90.163% |
| BIOLASE, Inc. | -17.93 Million USD | 62.273% |
| Beyond Air, Inc. | -63 Million USD | 89.26% |
| FONAR Corporation | 16.53 Million USD | 140.925% |
| AxoGen, Inc. | -21.46 Million USD | 68.469% |
| Vivani Medical, Inc. | -26.96 Million USD | 74.904% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 137.51% |
| Inari Medical, Inc. | -14.03 Million USD | 51.773% |
| UFP Technologies, Inc. | 57.66 Million USD | 111.735% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -37.332% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -7.317% |
| Tenon Medical, Inc. | -15.72 Million USD | 56.971% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | 9.457% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 84.154% |
| AdaptHealth Corp. | -598.4 Million USD | 98.869% |
| Sintx Technologies, Inc. | -13.35 Million USD | 49.34% |
| NanoVibronix, Inc. | -3.43 Million USD | -96.949% |
| Quanterix Corporation | -49.7 Million USD | 86.384% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 44.225% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -1671.507% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 97.977% |
| TransMedics Group, Inc. | -28.72 Million USD | 76.443% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 71.34% |
| NeuroMetrix, Inc. | -7.15 Million USD | 5.375% |
| Hyperfine, Inc. | -48.11 Million USD | 85.935% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 89.593% |
| Biomerica, Inc. | -6.36 Million USD | -6.285% |
| Bone Biologics Corporation | -9.42 Million USD | 28.225% |
| AVITA Medical, Inc. | -40.4 Million USD | 83.25% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | 34.371% |
| Silk Road Medical, Inc | -59.27 Million USD | 88.583% |